Analyst Ratings For NYSE:GMED – Globus Medical (NYSE:GMED)

.

Some recent analyst ratings include

• 4/16/2018-BTIG Research Reiterated Rating of Buy .
• 3/28/2018-Leerink Swann Reiterated Rating of Outperform .
• 3/12/2018-Canaccord Genuity Reiterated Rating of Buy.
• 1/10/2018-Barclays Reiterated Rating of Sell.

Recent Insider Trading Activity For NYSE:GMED – Globus Medical (NYSE:GMED)
NYSE:GMED – Globus Medical (NYSE:GMED) has insider ownership of 28.21% and institutional ownership of 65.57%.

• On 4/30/2018 David C Paul, Insider, sold 827,004 with an average share price of $51.81 per share and the total transaction amounting to $42,847,077.24.
• On 4/26/2018 David C Paul, Chairman, sold 725,000 with an average share price of $51.81 per share and the total transaction amounting to $37,562,250.00.
• On 4/19/2018 David M Demski, CEO, sold 149,109 with an average share price of $51.00 per share and the total transaction amounting to $7,604,559.00.
• On 4/13/2018 David M Demski, CEO, sold 50,891 with an average share price of $51.00 per share and the total transaction amounting to $2,595,441.00.
• On 4/10/2018 Daniel T Scavilla, VP, sold 100,000 with an average share price of $50.00 per share and the total transaction amounting to $5,000,000.00.
• On 3/28/2018 Eric Schwartz, VP, sold 24,000 with an average share price of $50.00 per share and the total transaction amounting to $1,200,000.00.
• On 12/15/2017 Steven Payne, CAO, sold 3,076 with an average share price of $39.30 per share and the total transaction amounting to $120,886.80.

Recent Trading Activity for NYSE:GMED – Globus Medical (NYSE:GMED)
Shares of NYSE:GMED – Globus Medical closed the previous trading session at 47.79 down -1.86 3.75% with 51.599998474121094 shares trading hands.